Trial · NCT07911722
A Patient Navigation Trial for Housing and Health (PATHH)
NCT07911722, Not applicable, Not yet recruiting, Friends Research Institute, Inc.
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. A Patient Navigation Trial for Housing and Health (PATHH). Trials, record NCT07911722. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07911722
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Patient Navigation Trial for Housing and Health (PATHH)
- NCT number
- NCT07911722
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 300 participants, estimated
- Lead sponsor
- Friends Research Institute, Inc.
- Conditions
- Housing Instability, Health and Social Services
- Interventions
- PATHH
- First posted
- 2026-11-03
- Last updated
- 2026-11-06
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Housing Stability | 6-months from departure or discharge from the emergency shelter stay | The primary outcome examining housing stability will be defined as obtaining housing (yes/no) within 6-months following departure from the emergency shelter stay. Housing will be inclusive of placements into transitional, supportive, and/or permanent housing locations and will be consistent with the Department of Housing and Urban Development (HUD) definition of stable housing, indicating any housing that meets safety standards and where the occupant has the rights and responsibilities of a tenant. |
| Primary | Health self-efficacy | 6-months from departure or discharge from the emergency shelter stay | Healthcare self-efficacy will be operationalized using the 22-item Patient Activation Measure (PAM81). The PAM is a reliable and valid measure that has demonstrated strong psychometric properties in several contexts and settings and assesses an individual's knowledge, skills, and confidence in managing their health needs and navigating health systems. Scores from PAM item responses are categorized into four levels of activation, ranging from Level 1 (the patient is disengaged and overwhelmed, and adherence is poor) to Level 4 (the patient has high health knowledge and maintaining health lifestyle is the focus). |
| Secondary | Housing Insecurity | 3-, 6- and 12- months post enrollment | Perceptions of Housing Insecurity will be assessed through a 2-item Health Related Social Needs screening tool that assesses the current living situation and its perception of stability, decency and safety in terms of heat, pests, lead paint, water leaks, and other housing conditions. A positive screening result indicates greater housing insecurity or unmet housing-related needs. |
| Secondary | Housing Instability | 3-, 6-, and 12-months post enrollment | Perceptions of housing instability will be assessed using the Housing Instability Scale, which is a seven-item scale that was created and validated among survivors of domestic violence, with higher scores indicating greater housing instability. Scores range from 0 to 7, with higher scores indicating greater housing instability. |
| Secondary | Social Support | 3-, 6- and 12-months post enrollment | Social Support: Social support will be measured using the Medical Outcomes Study (MOS) Social Support Survey, a 19-item questionnaire. Responses will be transformed to a standardized scale ranging from 0 to 100, with higher scores indicating greater perceived availability of social support. |
| Secondary | Global Health | 3-, 6-, and 12-months post enrollment | Physical, social, and mental health functioning will be assessed through the Promis 10 Global Health scale. Possible scores range from 16.2 to 67.7 for physical health and 21.2 to 67.6 for mental health. Higher scores indicate better health functioning. |
| Secondary | Mental Health Symptoms | 3-, 6-, 12- months post enrollment | PHQ-8 will be used to assess depressive symptoms; total scores range from 0 to 24, with higher scores indicating greater depressive symptom severity. |
| Secondary | History of Violence | 3-, 6-, and 12-months post enrollment. | Lifetime exposure to stressful and potentially traumatic events will be assessed using the 13-item Stressful Life Events Screening Questionnaire (SLESQ). The instrument assesses exposure to events such as life-threatening accidents, physical and sexual assault, and witnessing violence. Each event category is assessed using a yes/no response, with additional questions characterizing the exposure. The total score is calculated by summing the number of event categories endorsed, ranging from 0 to 13, with higher scores indicating greater lifetime exposure to potentially traumatic events. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| R01NR021987 | A Patient Navigation Trial for Housing and Health (PATHH): A randomized controlled trial | ALEXANDER, KAREN; NORDECK, COURTNEY | FRIENDS RESEARCH INSTITUTE, INC. | NATIONAL INSTITUTE OF NURSING RESEARCH | 2025 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07911722
GET https://conductscience.org/api/trials/v1/NCT07911722/registered